Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 3386
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT06597656 | A Gene Transfer Therapy to Evaluate the Safety and Efficacy of Delandistrogene Moxeparvovec (SRP-9001) Following Therapeutic Plasma Exchange (Plasmapheresis) in Participants With Duchenne Muscular Dystrophy (DMD) and Pre-existing Antibodies to AAVrh74 | ||
| NCT02657330 | Study of SBP-101 in Pancreatic Cancer | ||
| NCT05762471 | Phase 1b/2a Study of GSBR-1290 in Adult Overweight or Obese Healthy Subjects and Subjects With Type 2 Diabetes Mellitus | ||
| NCT05597345 | Selinexor for the Treatment of Intermediate and High-Risk Smoldering Multiple Myeloma | ||
| NCT02745912 | Study to Evaluate the Effect of Naltrexone and Bupropion Combination on the Pharmacokinetics of Metformin in Healthy Participants | ||
| NCT03970031 | A Study of MSDC-0602K to Assess Glycemic Control and Cardiovascular Outcomes in Patients With Pre-T2D or T2D and NAFLD/NASH | ||
| NCT00962637 | Study to Evaluate the Safety and Efficacy of Androxal™ Treatment in Men With Secondary Hypogonadism | ||
| NCT03575819 | A Phase 1 Study of FOR46 in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC) | ||
| NCT04900428 | Study to Evaluate a Single Intranasal Dose of STI-2099 (COVI-DROPS™) in Outpatient Adults With COVID-19 (UK) | ||
| NCT05448001 | Clinical Trial to Evaluate the Efficacy and Safety of JP-1366 in Patients With Gastric Ulcer | ||
| NCT01124565 | Safety Study of Two Repeat Doses of RT001 for the Treatment of Moderate to Severe Lateral Canthal Lines in Adults | ||
| NCT06326411 | A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors | ||
| NCT07487064 | Galvanize Aliya® EX Pulsed Electric Field (PEF) Treat and Resect Study | ||
| NCT05807971 | Assessment of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ATH-063 in Healthy Subjects | ||
| NCT04581629 | Safety, Tolerability, and Efficacy of Encaleret in Participants With Autosomal Dominant Hypocalcemia (ADH) Type 1 | ||
| NCT06226545 | A Study to Evaluate the Efficacy and Safety of LASN01 in Patients With Thyroid Eye Disease | ||
| NCT07262567 | Phase III Study to Compare GFH375 and Chemotherapy in Patients With KRAS G12D-Mutant Metastatic Pancreatic Cancer | ||
| NCT07104500 | VK2735 for Weight Management Phase 3 | ||
| NCT06026254 | A Rollover Study for Subjects Who Completed Participation in IMSA101-101 Trial | ||
| NCT02431429 | Spermiogram Assessment in Bolivian Patients Taking Impavido® (Miltefosine) for Mucocutaneous Leishmaniasis | ||
| NCT02274181 | An Open-Label, Single-Dose Study to Assess the Absorption, Metabolism, Excretion, and Mass Balance of Radiolabeled Androxal in Healthy Male Subjects After Oral Administration | ||
| NCT07205081 | Safety, Tolerability and PK of ATTO-3712 in Healthy Volunteers and Patients With Atopic Dermatitis | ||
| NCT04221230 | Study in Major Depressive Disorder With NMRA-335140 (BTRX-335140) vs Placebo | ||
| NCT06008483 | A Dose Finding Study to Treat Bone Tumor(s) | ||
| NCT07197554 | A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies | ||
| NCT06896188 | 9-ING-41 Combined With Retifanlimab, Plus Modified FOLFIRINOX for Patients With Advanced Pancreatic Adenocarcinoma (RiLEY) | ||
| NCT03786770 | Efficacy and Safety of DaxibotulinumtoxinA (DAXI) for Injection for Treatment of Forehead Lines (Frontalis) | ||
| NCT02301156 | Ublituximab in Combination With Ibrutinib Versus Ibrutinib Alone in Participants With Previously Treated High-Risk Chronic Lymphocytic Leukemia (CLL) | ||
| NCT06641557 | A Phase I Dosing Study of IkT-148009. | ||
| NCT05071183 | A Study of Repotrectinib in Combination With Other Anticancer Therapies for the Treatment of Subjects With KRAS-Mutant Solid Tumors | ||
| NCT01147172 | Safety Study of Cosmetic Tissue Augmentation in People of Color | ||
| NCT04420754 | Study of AIC100 CAR T Cells in Relapsed/Refractory Thyroid Cancer | ||
| NCT05712356 | A Study of LSTA1 When Added to Standard of Care Versus Standard of Care Alone in Patients With Advanced Solid Tumors | ||
| NCT02324673 | Cannabidiol Oral Solution in Pediatric Participants With Treatment-resistant Seizure Disorders | ||
| NCT03911102 | Efficacy and Safety of Increasing Doses of DaxibotulinumtoxinA for Injection (DAXI for Injection) in the Treatment of Moderate or Severe Lateral Canthal Lines | ||
| NCT07489430 | DaxibotulinumtoxinA for Blepharospasm | ||
| NCT04608500 | A Study (Study 2) to Evaluate the Safety and Efficacy of FMX103 1.5% Topical Minocycline Foam in the Treatment of Facial Papulopustular Rosacea | ||
| NCT06624644 | A Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory Melanoma | ||
| NCT04246281 | The RESET Clinical Trial: SPRINT® Peripheral Nerve Stimulation for the Treatment of Back Pain | ||
| NCT05153434 | A Study of Oral ARD-101 in Patients With Prader-Willi Syndrome | ||
| NCT05211284 | Saroglitazar Magnesium 4 mg for Nonalcoholic Fatty Liver Disease (NAFLD) in People Living With HIV in the US | ||
| NCT07197034 | The Hunger Elimination or Reduction Objective (HERO ) Open -Label Extension (OLE) Trial | ||
| NCT05712707 | Sublingual Dexmedetomidine for Treating Opioid Withdrawal | ||
| NCT02344511 | Dalbavancin vs Comparator in Pediatric Subjects With Acute Hematogenous Osteomyelitis | ||
| NCT05065216 | Treatment of Acute Ischemic Stroke (ReMEDy2 Trial) | ||
| NCT01447407 | Effect of Adjuvant & Route of Administration on Safety & Immunogenicity of NDV-3 Vaccine | ||
| NCT06964230 | A Phase 2b/3 Clinical Study Evaluating T3D-959 in Mild-to-Moderate Alzheimer's Disease Subjects | ||
| NCT01105598 | A Multiple Ascending Dose Study of ETC-1002 in Subjects With Mild Dyslipidemia | ||
| NCT00780598 | Safety and Anti-Disease Activity of Oral Tosedostat (CHR-2797) in Elderly Subjects With Refractory or Relapsed AML | ||
| NCT07219407 | A Long-term Study of the Safety and Effectiveness of RAP-219 in Adults With Focal Onset Seizures |
